scispace - formally typeset
A

Anton C. Schoolwerth

Researcher at Dartmouth–Hitchcock Medical Center

Publications -  49
Citations -  11932

Anton C. Schoolwerth is an academic researcher from Dartmouth–Hitchcock Medical Center. The author has contributed to research in topics: Kidney disease & Population. The author has an hindex of 26, co-authored 49 publications receiving 11330 citations. Previous affiliations of Anton C. Schoolwerth include Virginia Commonwealth University & VCU Medical Center.

Papers
More filters
Journal Article

PEER REVIEWED: Chronic Kidney Disease: A Public Health Problem That Needs a Public Health Action Plan

TL;DR: A broad and coordinated public health approach will be necessary to meet the burgeoning health, economic, and societal challenges of chronic kidney disease.
Journal ArticleDOI

Comprehensive Public Health Strategies for Preventing the Development, Progression, and Complications of CKD: Report of an Expert Panel Convened by the Centers for Disease Control and Prevention

TL;DR: The panel recommended a 10-point plan to improve surveillance, screening, education, and awareness directed at 3 target populations: people with CKD or at increased risk of developing CKD; providers, hospitals, and clinical laboratories; and the general public.
Journal Article

Chronic kidney disease: a public health problem that needs a public health action plan.

TL;DR: For a health problem or condition to be considered a public health issue, four criteria must be met: 1) the health condition must place a large burden on society, a burden that is getting larger despite existing control efforts; 2) the burden must be distributed unfairly (i.e., certain segments of the population are unequally affected); 3) there must be evidence that upstream preventive strategies could substantially reduce the burden of the condition; and 4) such preventive strategies are not yet in place.
Journal ArticleDOI

Does Safe Dosing of Iodinated Contrast Prevent Contrast-Induced Acute Kidney Injury?

TL;DR: Contrast volume is a key risk factor for CI-AKI and matters the most in the highest-risk patient and the incremental use of contrast beyond the MACD is associated with an increased risk of CI- AKI.